Firategrast
Modify Date: 2025-09-21 07:19:26
Firategrast structure
|
Common Name | Firategrast | ||
|---|---|---|---|---|
| CAS Number | 402567-16-2 | Molecular Weight | 499.50300 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C27H27F2NO6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of FirategrastFirategrast is an orally bioavailable α4β1/α4β7 integrin antagonist. |
| Name | (2S)-2-[(2,6-difluorobenzoyl)amino]-3-[4-[4-(ethoxymethyl)-2,6-dimethoxyphenyl]phenyl]propanoic acid |
|---|---|
| Synonym | More Synonyms |
| Description | Firategrast is an orally bioavailable α4β1/α4β7 integrin antagonist. |
|---|---|
| Related Catalog | |
| Target |
α4β1/α4β7[1] |
| In Vitro | Firategrast is an orally bioavailable α4β1/α4β7 integrin antagonist designed to reduce trafficking of lymphocytes into the central nervous system (CNS)[1]. |
| References |
| Molecular Formula | C27H27F2NO6 |
|---|---|
| Molecular Weight | 499.50300 |
| Exact Mass | 499.18100 |
| PSA | 97.58000 |
| LogP | 5.18600 |
| Storage condition | 2-8℃ |
| Firategrast (USAN) |
| Firategrast |
| UNII-OJY3SK9H5F |